Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Six-Month Response to Delamanid Treatment in MDR TB Patients.
Hewison C, Ferlazzo G, Avaliani Z, Hayrapetyan A, Jonckheere S, Khaidarkhanova Z, Mohr E, Sinha A, Skrahina A, Vambe D, Vasilyeva I, Lachenal N, Varaine F. Hewison C, et al. Among authors: sinha a. Emerg Infect Dis. 2017 Oct;23(10):1746-8. doi: 10.3201/eid2310.170468. Epub 2017 Oct 17. Emerg Infect Dis. 2017. PMID: 28767036 Free PMC article.
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.
Tadolini M, Garcia-Prats AJ, D'Ambrosio L, Hewison C, Centis R, Schaaf HS, Marais BJ, Ferreira H, Caminero JA, Jonckheere S, Sinha A, Herboczek K, Khaidarkhanova Z, Hayrapetyan A, Khachatryan N, Urtkmelidze Ia, Loreti C, Esposito S, Matteelli A, Furin J, Varaine F, Migliori GB. Tadolini M, et al. Among authors: sinha a. Eur Respir J. 2016 Sep;48(3):938-43. doi: 10.1183/13993003.00705-2016. Epub 2016 Jun 23. Eur Respir J. 2016. PMID: 27338197 Free PMC article.
Patient and health-care provider experience of a person-centred, multidisciplinary, psychosocial support and harm reduction programme for patients with harmful use of alcohol and drug-resistant tuberculosis in Minsk, Belarus.
Harrison RE, Shyleika V, Falkenstein C, Garsevanidze E, Vishnevskaya O, Lonnroth K, Sayakci Ö, Sinha A, Sitali N, Skrahina A, Stringer B, Tan C, Mar HT, Venis S, Vetushko D, Viney K, Vishneuski R, Carrion Martin AI. Harrison RE, et al. Among authors: sinha a. BMC Health Serv Res. 2022 Sep 30;22(1):1217. doi: 10.1186/s12913-022-08525-x. BMC Health Serv Res. 2022. PMID: 36180873 Free PMC article.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team. Nyang'wa BT, et al. Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16. Lancet Respir Med. 2024. PMID: 37980911 Free article. Clinical Trial.
Supporting multidrug-resistant or rifampicin-resistant TB treatment adherence in people with harmful use of alcohol through person-centred care.
Harrison RE, Shyleika V, Vishneuski R, Leonovich O, Vetushko D, Skrahina A, Mar HT, Garsevanidze E, Falkenstein C, Sayakci Ö, Martin AIC, Tan C, Sitali N, Viney K, Lonnroth K, Stringer B, Ariti C, Sinha A. Harrison RE, et al. Among authors: sinha a. Int Health. 2024 Nov 6:ihae066. doi: 10.1093/inthealth/ihae066. Online ahead of print. Int Health. 2024. PMID: 39501994
Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan.
Nair P, Hasan T, Zaw KK, Allamuratova S, Ismailov A, Mendonca P, Bekbaev Z, Parpieva N, Singh J, Sitali N, Bermudez-Aza E, Sinha A. Nair P, et al. Among authors: sinha a. Int J Tuberc Lung Dis. 2022 Jul 1;26(7):658-663. doi: 10.5588/ijtld.21.0631. Int J Tuberc Lung Dis. 2022. PMID: 35768925 Free PMC article.
Household drug-resistant TB contact tracing in Tajikistan.
Rekart ML, Aung A, Cullip T, Mulanda W, Mun L, Pirmahmadzoda B, Kliescokova J, Achar J, Alvarez JL, Sitali N, Sinha A. Rekart ML, et al. Among authors: sinha a. Int J Tuberc Lung Dis. 2023 Oct 1;27(10):748-753. doi: 10.5588/ijtld.23.0066. Int J Tuberc Lung Dis. 2023. PMID: 37749832 Free PMC article.
Prevalence, treatment, and outcomes of hepatitis C in an MDR/RR-TB trial cohort.
Jansen van Vuuren J, Crocker-Buque T, Berry C, Viatushka D, Usmanova R, Nyang'wa BT, Parpieva N, Liverko I, Solodovnikova V, Sinha A. Jansen van Vuuren J, et al. Among authors: sinha a. PLOS Glob Public Health. 2024 Sep 24;4(9):e0003057. doi: 10.1371/journal.pgph.0003057. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39316626 Free PMC article.
4,397 results